New drug cocktail aims to fight Late-Stage pancreatic cancer
Disease control
Recruiting now
This study tests a combination of three drugs (regorafenib, toripalimab, and albumin-bound paclitaxel) as a third-line treatment for people with advanced pancreatic cancer that has spread or cannot be removed. The goal is to see if this mix can slow tumor growth and improve survi…
Phase: PHASE1, PHASE2 • Sponsor: Junjie Hang • Aim: Disease control
Last updated May 26, 2026 10:29 UTC